Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral Vasodilation in Obese Humans
NCT02833207Phase 1Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Apr 2012
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of NG-monomethyl-L-arginine and ketorolac in obesity, sponsored by University of Wisconsin–Madison. Started Apr 2012; status: terminated.
02
Drugs
NG-monomethyl-L-arginineketorolac
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02833207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02833207.